1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
8031U |
Child Drug Exposure Screen, Urine |
8091B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
8091FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
8091SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8091TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
8091U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8101B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
8101FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
8101SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |